Hakutulokset - Kovacsovics-Bankowski, Magdalena
- Näytetään 1 - 10 yhteensä 10 tuloksesta
-
1
-
2
-
3
Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis Tekijä Kovacsovics-Bankowski, Magdalena, Chisholm, Lana, Vercellini, Jonna, Crittenden, Marka, Lary, Scot, Curti, Brendan, Weinberg, Andrew
Julkaistu 2013Teksti -
4
Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2(V617F) allelic... Tekijä Kovacsovics-Bankowski, Magdalena, Kelley, Todd W., Efimova, Olga, Kim, Soo Jin, Wilson, Andrew, Swierczek, Sabina, Prchal, Josef
Julkaistu 2016Teksti -
5
Two Adjacent Trimeric Fas Ligands Are Required for Fas Signaling and Formation of a Death-Inducing Signaling Complex Tekijä Holler, Nils, Tardivel, Aubry, Kovacsovics-Bankowski, Magdalena, Hertig, Sylvie, Gaide, Olivier, Martinon, Fabio, Tinel, Antoine, Deperthes, David, Calderara, Silvio, Schulthess, Therese, Engel, Jürgen, Schneider, Pascal, Tschopp, Jürg
Julkaistu 2003Teksti -
6
CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma Tekijä Yousef, Sara, Kovacsovics-Bankowski, Magdalena, Salama, Mohamed E, Bhardwaj, Neelam, Steinbach, Mary, Langemo, Amanda, Kovacsovics, Tibor, Marvin, James, Binder, Mascha, Panse, Jens, Kröger, Nicolaus, Luetkens, Tim, Atanackovic, Djordje
Julkaistu 2015Teksti -
7
Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities Tekijä Kovacsovics-Bankowski, Magdalena, Chisholm, Lana, Vercellini, Jonna, Tucker, Christopher G, Montler, Ryan, Haley, Daniel, Newell, Philippa, Ma, Jun, Tseng, Paul, Wolf, Ronald, Vetto, John T, Hammill, Chet, Hansen, Paul, Weinberg, Andrew D
Julkaistu 2014Teksti -
8
Signaling through OX40 Enhances Anti-tumor Immunity Tekijä Jensen, Shawn M., Maston, Levi D., Gough, Michael J., Ruby, Carl E., Redmond, William L., Crittenden, Marka, Li, Yuhuan, Puri, Sachin, Poehlein, Christian H., Morris, Nick, Kovacsovics-Bankowski, Magdalena, Moudgil, Tarsem, Twitty, Chris, Walker, Edwin B., Hu, Hong-Ming, Urba, Walter J., Weinberg, Andrew D., Curti, Brendan D, Fox, Bernard A.
Julkaistu 2010Teksti -
9
OX40 is a potent immune stimulating target in late stage cancer patients Tekijä Curti, Brendan D., Kovacsovics-Bankowski, Magdalena, Morris, Nicholas, Walker, Edwin, Chisholm, Lana, Floyd, Kevin, Walker, Joshua, Gonzalez, Iliana, Meeuwsen, Tanisha, Fox, Bernard A., Moudgil, Tarsem, Miller, William, Haley, Daniel, Coffey, Todd, Fisher, Brenda, Delanty-Miller, Laurie, Rymarchyk, Nicole, Kelly, Tracy, Crocenzi, Todd, Bernstein, Eric, Sanborn, Rachel, Urba, Walter J., Weinberg, Andrew D.
Julkaistu 2013Teksti -
10
Adjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma Tekijä Grossmann, Kenneth F., Othus, Megan, Patel, Sapna P., Tarhini, Ahmad A., Sondak, Vernon K., Knopp, Michael V., Petrella, Teresa M., Truong, Thach-Giao, Khushalani, Nikhil I., Cohen, Justine V., Buchbinder, Elizabeth I., Kendra, Kari, Funchain, Pauline, Lewis, Karl D., Conry, Robert M., Chmielowski, Bartosz, Kudchadkar, Ragini R., Johnson, Douglas B., Li, Hongli, Moon, James, Eroglu, Zeynep, Gastman, Brian, Kovacsovics-Bankowski, Magdalena, Gunturu, Krishna S., Ebbinghaus, Scot W., Ahsan, Sama, Ibrahim, Nageatte, Sharon, Elad, Korde, Larissa A., Kirkwood, John M., Ribas, Antoni
Julkaistu 2022Teksti